You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -293.2% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -22.4 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 66.4 | 0.0 |
| Price / Book value | 8.7 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 33.7% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-11-30 | 0.29 | -1.52 | -1.67p | -38.9 | 0.0 | n/a | n/a | 0.0% |
| 2017-11-30 | 0.19 | 1.69 | 2.43p | 28.4 | 0.0 | n/a | n/a | 0.0% |
| 2018-11-30 | 0.51 | -1.95 | -2.30p | -40.7 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.74 | -2.24 | -2.30p | -28.8 | 0.0 | n/a | n/a | 0.0% |
| OptiBiotix grants LPLDL licence to Canada's Genuine Health Sharecast News | 18 Nov |
|---|---|
| OptiBiotix products launch into retail in Australia, New Zealand Sharecast News | 12 Oct |
| OptiBiotix shares rise as partner Seed gets FDA approval Sharecast News | 02 Oct |
| Director Appointment | 02-Mar-21 07:00 |
|---|---|
| Investor update | 24-Feb-21 07:00 |
| Strategy and commercial update | 18-Feb-21 07:00 |
| Proposed Director appointment | 02-Feb-21 09:31 |
| New appointments | 19-Jan-21 08:08 |